{"title":"酒精使用障碍患者的健康相关生活质量:从临床措施到基于偏好的措施比较工具和制图","authors":"Eva Rodríguez-Míguez, Jacinto Mosquera","doi":"10.1007/s10198-025-01816-0","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objectives: </strong>The impact of alcohol use disorder (AUD) on quality of life can be quantified by generic and specific measures. This study's aims are to compare different preference-based instruments to measure health-related quality of life (HRQoL) in patients with AUD and to examine their relationship with alcohol-specific measures used in the clinical setting.</p><p><strong>Methods: </strong>A sample of 259 patients with AUD were recruited from a Spanish alcoholism unit. We administered EuroQoL-5Dimension -5levels (EQ-5D), ShortForm-6Dimension (SF-6D), AlcoholQuality-of-life-4Dimension (AlcQ-4D), Diagnostic and Statistical Manual of Mental Disorders (DSM-5), and Alcohol Use Disorders Identification Test (AUDIT) instruments at the beginning of treatment and 12 months thereafter. Differences in HRQoL instruments scores were estimated and their capacity to discriminate among known clinical severity groups was analysed. Several mapping functions were tested to transform scores from the clinical setting (AUDIT or DSM-5) into HRQoL scores (EQ-5D, SF-6D or AlcQ-4D).</p><p><strong>Results: </strong>HRQoL scores are sensitive to the instrument used. Mean scores are always highest using EQ-5D, followed by SF-6D and AlcQ-4D. All HRQoL instruments discriminate among clinical severity groups defined using DSM-5 or AUDIT. Although several mapping functions were estimated, those using the total score of the clinical instruments were selected.</p><p><strong>Conclusion: </strong>The results suggest that clinical measures used in the field of AUD could be adapted for use in economic evaluation. However, the incremental cost-utility ratio of AUD programs, and hence the policy decisions derived from it, may depend on the HRQoL instrument used.</p>","PeriodicalId":51416,"journal":{"name":"European Journal of Health Economics","volume":" ","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Health-related quality of life in patients with alcohol use disorder: comparing instruments and mapping from clinical measures to preference-based measures.\",\"authors\":\"Eva Rodríguez-Míguez, Jacinto Mosquera\",\"doi\":\"10.1007/s10198-025-01816-0\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background and objectives: </strong>The impact of alcohol use disorder (AUD) on quality of life can be quantified by generic and specific measures. This study's aims are to compare different preference-based instruments to measure health-related quality of life (HRQoL) in patients with AUD and to examine their relationship with alcohol-specific measures used in the clinical setting.</p><p><strong>Methods: </strong>A sample of 259 patients with AUD were recruited from a Spanish alcoholism unit. We administered EuroQoL-5Dimension -5levels (EQ-5D), ShortForm-6Dimension (SF-6D), AlcoholQuality-of-life-4Dimension (AlcQ-4D), Diagnostic and Statistical Manual of Mental Disorders (DSM-5), and Alcohol Use Disorders Identification Test (AUDIT) instruments at the beginning of treatment and 12 months thereafter. Differences in HRQoL instruments scores were estimated and their capacity to discriminate among known clinical severity groups was analysed. Several mapping functions were tested to transform scores from the clinical setting (AUDIT or DSM-5) into HRQoL scores (EQ-5D, SF-6D or AlcQ-4D).</p><p><strong>Results: </strong>HRQoL scores are sensitive to the instrument used. Mean scores are always highest using EQ-5D, followed by SF-6D and AlcQ-4D. All HRQoL instruments discriminate among clinical severity groups defined using DSM-5 or AUDIT. Although several mapping functions were estimated, those using the total score of the clinical instruments were selected.</p><p><strong>Conclusion: </strong>The results suggest that clinical measures used in the field of AUD could be adapted for use in economic evaluation. However, the incremental cost-utility ratio of AUD programs, and hence the policy decisions derived from it, may depend on the HRQoL instrument used.</p>\",\"PeriodicalId\":51416,\"journal\":{\"name\":\"European Journal of Health Economics\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2025-07-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Health Economics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s10198-025-01816-0\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ECONOMICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Health Economics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10198-025-01816-0","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ECONOMICS","Score":null,"Total":0}
Health-related quality of life in patients with alcohol use disorder: comparing instruments and mapping from clinical measures to preference-based measures.
Background and objectives: The impact of alcohol use disorder (AUD) on quality of life can be quantified by generic and specific measures. This study's aims are to compare different preference-based instruments to measure health-related quality of life (HRQoL) in patients with AUD and to examine their relationship with alcohol-specific measures used in the clinical setting.
Methods: A sample of 259 patients with AUD were recruited from a Spanish alcoholism unit. We administered EuroQoL-5Dimension -5levels (EQ-5D), ShortForm-6Dimension (SF-6D), AlcoholQuality-of-life-4Dimension (AlcQ-4D), Diagnostic and Statistical Manual of Mental Disorders (DSM-5), and Alcohol Use Disorders Identification Test (AUDIT) instruments at the beginning of treatment and 12 months thereafter. Differences in HRQoL instruments scores were estimated and their capacity to discriminate among known clinical severity groups was analysed. Several mapping functions were tested to transform scores from the clinical setting (AUDIT or DSM-5) into HRQoL scores (EQ-5D, SF-6D or AlcQ-4D).
Results: HRQoL scores are sensitive to the instrument used. Mean scores are always highest using EQ-5D, followed by SF-6D and AlcQ-4D. All HRQoL instruments discriminate among clinical severity groups defined using DSM-5 or AUDIT. Although several mapping functions were estimated, those using the total score of the clinical instruments were selected.
Conclusion: The results suggest that clinical measures used in the field of AUD could be adapted for use in economic evaluation. However, the incremental cost-utility ratio of AUD programs, and hence the policy decisions derived from it, may depend on the HRQoL instrument used.
期刊介绍:
The European Journal of Health Economics is a journal of Health Economics and associated disciplines. The growing demand for health economics and the introduction of new guidelines in various European countries were the motivation to generate a highly scientific and at the same time practice oriented journal considering the requirements of various health care systems in Europe. The international scientific board of opinion leaders guarantees high-quality, peer-reviewed publications as well as articles for pragmatic approaches in the field of health economics. We intend to cover all aspects of health economics:
• Basics of health economic approaches and methods
• Pharmacoeconomics
• Health Care Systems
• Pricing and Reimbursement Systems
• Quality-of-Life-Studies The editors reserve the right to reject manuscripts that do not comply with the above-mentioned requirements. The author will be held responsible for false statements or for failure to fulfill the above-mentioned requirements.
Officially cited as: Eur J Health Econ